XML 65 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation and Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Share-based Payment Arrangement, Cost by Plan
The following table sets forth stock-based compensation expense recognized by the Company in the following line items in the Company's consolidated statements of operations and comprehensive (loss) income during the periods presented:

 Years Ended December 31,
(in thousands)202420232022
Cost of services$662 $613 $421 
Sales and marketing7,351 11,089 6,634 
General and administrative16,105 10,499 7,573 
Stock-based compensation expense$24,118 $22,201 $14,628 
Schedule of Stock-based Compensation Expense
The following table sets forth the Company's stock-based compensation expense by award type during the periods presented:
 Years Ended December 31,
(in thousands)202420232022
RSUs$12,765 $9,637 $3,569 
PSUs9,747 9,372 3,141 
Stock Options459 1,674 6,156 
ESPP1,147 1,518 1,762 
Stock-based compensation expense $24,118 $22,201 $14,628 
Schedule of Nonvested Restricted Stock Shares Activity
The following table sets forth the Company's RSU activity during the years ended December 31, 2024, 2023 and 2022:
Number of Restricted Stock UnitsWeighted-Average Grant-Date Fair Value
Nonvested balance as of December 31, 2021
— — 
Granted525,735 $25.93 
Vested(890)— 
Forfeited(7,710)26.09 
Nonvested balance as of December 31, 2022
517,135 $25.93 
Granted709,175 19.58 
Vested(208,345)25.66 
Forfeited(25,501)23.20 
Nonvested balance as of December 31, 2023
992,464 $21.52 
Granted891,598 18.42 
Vested(455,517)22.10 
Forfeited(241,119)19.31 
Nonvested balance as of December 31, 2024
1,187,426 $19.42 
Schedule of Nonvested Performance-Based Units Activity
The following table sets forth the Company's PSU activity during the years ended December 31, 2024, 2023 and 2022:
Number of Performance-Based Restricted Stock UnitsWeighted-Average Grant-Date Fair Value
Nonvested balance as of December 31, 2021
— — 
Granted473,371 $26.76 
Vested— — 
Forfeited— — 
Nonvested balance as of December 31, 2022
473,371 $26.76 
Granted657,408 21.46 
Vested— — 
Forfeited— — 
Nonvested balance as of December 31, 2023
1,130,779 $23.68 
Granted693,936 18.89 
Vested(122,241)26.33 
Forfeited(352,116)22.31 
Nonvested balance as of December 31, 2024
1,350,358 $22.01 
Schedule of Stock Options, Valuation Assumptions
The following table sets forth the PSUs weighted-average fair values and assumptions used in the Monte Carlo simulation model during the periods presented:
 Years Ended December 31,
202420232022
Weighted-average fair value$18.80 $21.46 $27.21 
Dividend yield— — — 
Volatility51.13 %75.80 %77.12 %
Risk-free interest rate4.13 %4.14 %2.87 %
Expected life (in years)2.992.992.66
Schedule of Stock Option Activity
The following table sets forth the Company's stock options activity during the year ended December 31, 2024:

Number of Stock Option AwardsWeighted-Average Grant-Date Fair Value
Nonvested balance as of December 31, 2023
401,075 $12.62 
Granted— — 
Vested(401,075)12.62 
Forfeited— — 
Outstanding stock option awards expected to vest as of December 31, 2024
— N/A
Schedule of Outstanding Stock Option Activity
The following table reflects changes in the Company's outstanding stock option awards for the year ended December 31, 2024:
 2024
 Number of
Stock Option
Awards
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic Value (in thousands)
Outstanding stock option awards at January 13,309,222 $11.65 5.52$28,781 
Granted— — — 
Exercises (issuance of shares)(604,360)10.04 4.1390 
Forfeitures/expirations— — — 
Outstanding stock option awards as of December 312,704,862 $12.01 4.60$7,540 
 
Options exercisable as of December 312,704,862 $12.01 4.60$7,540 
The following table reflects changes in the Company's outstanding stock option awards for the year ended December 31, 2023:
 2023
 Number of
Stock Option
Awards
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic Value (in thousands)
Outstanding stock option awards at January 13,533,507 $11.62 6.52$26,070 
Granted— — — — 
Exercises (issuance of shares)(216,549)11.22 5.56173 
Forfeitures/expirations(7,736)10.35 6.9591 
Outstanding stock option awards at December 313,309,222 $11.65 5.52$28,781 
Options exercisable as of December 312,908,147 $11.52 5.39$25,682